Emergent

Products

Category

Product

Brand

Description

Global Markets for Vaccine Technologies (PHM014K)

ACAM2000		The ACAM2000 vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
BioThrax		The BioThrax vaccine is specified for the active vaccination against infection caused by Bacillus anthracis in persons 18-65 years of age. BioThrax is authorized for: pre- and post-exposure prophylaxis of infection in persons at extreme risk of exposure.
Cyfendus		CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted) is a vaccine indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment